Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on July 22, 2010, to announce its financial results for the second quarter of 2010. The filing primarily consists of a press release and supplemental information detailing the company's performance during the period. Investors should note that this 8-K serves as the official disclosure mechanism for these results. The accompanying press release (Exhibit 99.1) and supplemental data (Exhibit 99.2) are the primary sources of information for understanding BMY's operational and financial condition as of and for the second quarter of 2010.
Key Highlights
- 1BMY filed an 8-K on July 22, 2010, to report its Q2 2010 financial results.
- 2The filing includes a press release (Exhibit 99.1) detailing the financial outcomes.
- 3Supplemental financial information was also made available on the company's website (Exhibit 99.2).
- 4The 8-K confirms the company's adherence to SEC reporting requirements for material events.
- 5This report is the official source for BMY's Q2 2010 performance data.
- 6The filing was made subsequent to the event date of July 21, 2010.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide access to Bristol-Myers Squibb Company's financial results for the second quarter of 2010.
The detailed financial results are available in the press release furnished as Exhibit 99.1 to this 8-K filing and through certain supplemental information posted on the company's website, furnished as Exhibit 99.2.
This report covers the financial results for the second quarter of 2010.
While the quarterly earnings announcement is a routine event for publicly traded companies, this 8-K filing is the specific mechanism used to formally report these results to the SEC and the public, making it a required disclosure for material information.